Legal & General Group’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.21M | Sell |
42,302
-9,741
| -19% | -$332K | ﹤0.01% | 2085 |
|
|
2025
Q4 | $2.06M | Sell |
52,043
-4,849
| -9% | -$178K | ﹤0.01% | 1954 |
|
|
2025
Q3 | $2.01M | Buy |
56,892
+136
| +0.2% | +$4.69K | ﹤0.01% | 1979 |
|
|
2025
Q2 | $1.86M | Buy |
56,756
+2,056
| +4% | +$66.8K | ﹤0.01% | 1990 |
|
|
2025
Q1 | $1.76M | Sell |
54,700
-114
| -0.2% | -$4.23K | ﹤0.01% | 1974 |
|
|
2024
Q4 | $1.68M | Buy |
54,814
+4,968
| +10% | +$160K | ﹤0.01% | 2053 |
|
|
2024
Q3 | $1.4M | Buy |
49,846
+4,363
| +10% | +$108K | ﹤0.01% | 2113 |
|
|
2024
Q2 | $1.04M | Buy |
45,483
+278
| +0.6% | +$6.42K | ﹤0.01% | 2185 |
|
|
2024
Q1 | $1.38M | Buy |
45,205
+430
| +1% | +$14.4K | ﹤0.01% | 2079 |
|
|
2023
Q4 | $1.6M | Sell |
44,775
-191
| -0.4% | -$7.1K | ﹤0.01% | 2054 |
|
|
2023
Q3 | $1.97M | Buy |
44,966
+83
| +0.2% | +$4.05K | ﹤0.01% | 1904 |
|
|
2023
Q2 | $2.22M | Buy |
44,883
+2,865
| +7% | +$132K | ﹤0.01% | 1876 |
|
|
2023
Q1 | $1.74M | Buy |
42,018
+1,176
| +3% | +$48.8K | ﹤0.01% | 1941 |
|
|
2022
Q4 | $1.81M | Buy |
40,842
+1,276
| +3% | +$53.3K | ﹤0.01% | 1927 |
|
|
2022
Q3 | $1.55M | Sell |
39,566
-2,242
| -5% | -$103K | ﹤0.01% | 1978 |
|
|
2022
Q2 | $1.71M | Sell |
41,808
-206
| -0.5% | -$9.76K | ﹤0.01% | 1963 |
|
|
2022
Q1 | $2.76M | Buy |
42,014
+4,507
| +12% | +$292K | ﹤0.01% | 1838 |
|
|
2021
Q4 | $2.61M | Buy |
37,507
+108
| +0.3% | +$7.85K | ﹤0.01% | 1901 |
|
|
2021
Q3 | $2.6M | Buy |
37,399
+8,390
| +29% | +$646K | ﹤0.01% | 1895 |
|
|
2021
Q2 | $2.3M | Buy |
29,009
+6
| +0% | +$436 | ﹤0.01% | 1906 |
|
|
2021
Q1 | $1.9M | Buy |
29,003
+19,346
| +200% | +$1.19M | ﹤0.01% | 2000 |
|
|
2020
Q4 | $537K | Sell |
9,657
-51
| -0.5% | -$2.21K | ﹤0.01% | 2246 |
|
|
2020
Q3 | $388K | Sell |
9,708
-1,159
| -11% | -$49.1K | ﹤0.01% | 2248 |
|
|
2020
Q2 | $489K | Sell |
10,867
-318
| -3% | -$13.8K | ﹤0.01% | 2175 |
|
|
2020
Q1 | $376K | Sell |
11,185
-671
| -6% | -$24.1K | ﹤0.01% | 2147 |
|
|
2019
Q4 | $386K | Buy |
11,856
+1,709
| +17% | +$48.6K | ﹤0.01% | 2272 |
|
|
2019
Q3 | $253K | Buy |
10,147
+2,714
| +37% | +$77.5K | ﹤0.01% | 2305 |
|
|
2019
Q2 | $222K | Buy |
7,433
+314
| +4% | +$9.17K | ﹤0.01% | 2326 |
|
|
2019
Q1 | $190K | Buy |
7,119
+161
| +2% | +$4.89K | ﹤0.01% | 2342 |
|
|
2018
Q4 | $213K | Buy |
6,958
+1,646
| +31% | +$51.3K | ﹤0.01% | 2286 |
|
|
2018
Q3 | $186K | Hold |
5,312
| – | – | ﹤0.01% | 2345 |
|
|
2018
Q2 | $143K | Sell |
5,312
-896
| -14% | -$21.1K | ﹤0.01% | 2383 |
|
|
2018
Q1 | $127K | Sell |
6,208
-2,482
| -29% | -$44.8K | ﹤0.01% | 2420 |
|
|
2017
Q4 | $159K | Buy |
8,690
+304
| +4% | +$6.02K | ﹤0.01% | 2407 |
|
|
2017
Q3 | $188K | Sell |
8,386
-142
| -2% | -$3.21K | ﹤0.01% | 2363 |
|
|
2017
Q2 | $208K | Buy |
8,528
+312
| +4% | +$6.63K | ﹤0.01% | 2285 |
|
|
2017
Q1 | $157K | Sell |
8,216
-112
| -1% | -$1.96K | ﹤0.01% | 2338 |
|
|
2016
Q4 | $164K | Buy |
8,328
+2,861
| +52% | +$51.9K | ﹤0.01% | 2313 |
|
|
2016
Q3 | $84K | Hold |
5,467
| – | – | ﹤0.01% | 2285 |
|
|
2016
Q2 | $78K | Hold |
5,467
| – | – | ﹤0.01% | 2232 |
|
|
2016
Q1 | $93K | Buy |
5,467
+1,282
| +31% | +$22.6K | ﹤0.01% | 2097 |
|
|
2015
Q4 | $93K | Hold |
4,185
| – | – | ﹤0.01% | 2115 |
|
|
2015
Q3 | $88K | Hold |
4,185
| – | – | ﹤0.01% | 2116 |
|
|
2015
Q2 | $102K | Hold |
4,185
| – | – | ﹤0.01% | 2101 |
|
|
2015
Q1 | $86K | Hold |
4,185
| – | – | ﹤0.01% | 2142 |
|
|
2014
Q4 | $82K | Hold |
4,185
| – | – | ﹤0.01% | 2112 |
|
|
2014
Q3 | $60K | Buy |
+4,185
| New | +$66.7K | ﹤0.01% | 2277 |
|
Other funds holding ATRC
HRCM
VPM
VCM
NAMI
Legal & General Group's ATRC Position: Q1 2026 in Review
Legal & General Group reduced its AtriCure (ATRC) stake by 19% in Q1 2026, selling an estimated $332K and leaving 42,302 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2085.
Legal & General Group first reported a position in ATRC in Q3 2014 and has held it in 47 quarters since. The position peaked at $2.76M in Q1 2022. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.
- Legal & General Group held 42,302 shares of AtriCure worth $1.21M as of Q1 2026.
- Legal & General Group sold 9,741 AtriCure shares in Q1 2026, an estimated $332K.
- AtriCure made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2085 holding.
- Legal & General Group first reported a position in AtriCure in Q3 2014 and has held it in 47 quarters since.
- Legal & General Group's AtriCure position peaked at $2.76M in Q1 2022.
- 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.
Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.